In addition, we demonstrated that the FXR has a protective effect on cholestatic liver injury and improves intestinal epithelial cell apoptosis in BDL rats, thus providing a new potential target for clinical prevention of intestinal mucosal barrier injury in patients with obstructive jaundice. The gene discussed is NR1H4; the disease is obstructive jaundice.